Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern Time
Rhea-AI Summary
Senseonics (NASDAQ: SENS) will release first quarter 2026 financial results after market close on Thursday, May 7, 2026. Management will host a conference call and concurrent webcast at 4:30 p.m. Eastern Time the same day.
The webcast link will be available via the company website under Investor Relations > Events & Publications and will be archived. Dial-in numbers: 1-800-225-9448 (US/Canada) or 1-203-518-9708 (International); passcode SENSQ1. Callers are asked to dial in approximately ten to five minutes before the start time.
Positive
- None.
Negative
- None.
News Market Reaction – SENS
In the May 1 session, SENS declined 22.84%, reflecting a significant negative market reaction. Argus tracked a trough of -9.9% from its starting point during tracking. Our momentum scanner triggered 23 alerts that day, indicating elevated trading interest and price volatility. Trading volume was exceptionally heavy at 18.1x the daily average, suggesting significant selling pressure.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Conferences,earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Oct 22 | Earnings call scheduling | Neutral | +6.1% | Scheduled Q3 2025 earnings release and 4:30 p.m. Eastern conference call. |
| Jul 16 | Earnings call scheduling | Neutral | +5.0% | Set Q2 2025 earnings release date and post-close conference call details. |
| Apr 29 | Earnings call scheduling | Neutral | -0.7% | Announced Q1 2025 earnings date and multi-channel investor access information. |
| Feb 12 | Earnings call scheduling | Neutral | +12.0% | Outlined Q4 and full-year 2024 release timing and access instructions. |
| Oct 24 | Earnings call scheduling | Neutral | +1.7% | Planned Q3 2024 results release and 4:30 p.m. earnings conference call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Scheduling earnings calls has usually coincided with modestly positive one-day moves, with one notable negative reaction.
Recent history for Senseonics around scheduled earnings events shows generally constructive reactions. Five prior conferences,earnings notices from Oct 2024 through Oct 2025 led to one-day moves ranging from about -0.65% to 11.97%, averaging roughly 4.8%. Most announcements simply set the release date and 4:30 p.m. Eastern call time, yet the stock often moved higher, suggesting investors treat these as markers ahead of fuller financial updates rather than catalysts themselves.
Key Terms
continuous glucose monitoring (CGM) medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
GERMANTOWN, Md., May 01, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its first quarter 2026 financial results after market close on Thursday, May 7, 2026.
Management will hold a conference call to review the Company’s first quarter 2026 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by navigating to “Investor Relations,” and then “Events & Publications,” and will be archived there for future reference. To listen to the conference call, please dial 1-800-225-9448 (US/Canada) or 1-203-518-9708 (International), passcode SENSQ1, approximately ten to five minutes prior to start time.
About Senseonics
Senseonics Holdings, Inc. ("Senseonics") is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems Eversense® 365 and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.
Senseonics Investor Contact
Jeremy Feffer
LifeSci Advisors
investors@senseonics.com
